Peters on Diabetes

• What's New in the 2019 Standards of Medical Care in Diabetes   From telemedicine to patient education and lifestyle management, Dr Peters highlights key changes to this year's ADA standards for diabetes care.
  Medscape Diabetes & Endocrinology, February 2019
• Teaching Patients How to Use Inhaled Insulin   Dr Anne Peters says that the key to getting patients to comfortably use inhaled insulin is in the teaching. Mark Harmel demonstrates how.
  Medscape Diabetes & Endocrinology, January 2019
• Putting the ADA/EASD Glycemic Management Algorithm to Use   The recent ADA/EASD guideline on managing hyperglycemia in T2D is complicated and may seem daunting. Dr Anne Peters simplifies and reviews the key frames of the guideline.
  Medscape Diabetes & Endocrinology, January 2019
• Making the Switch: When Your Patient Can't Afford Insulin   For many patients, analogue insulin is simply unaffordable, but using non-analogue insulin can get complicated. Dr Anne Peters shares her tips and tricks for making a safe transition.
  Medscape Diabetes & Endocrinology, January 2019
• Cardiovascular Outcomes Trials Give 'Comforting' Results   Dr Anne Peters gives us her take on the recent CARMELINA, DECLARE-TIMI, and REWIND trials and their cardiovascular outcomes.
  Medscape Diabetes & Endocrinology, December 2018
• 'Life Behind the 8-Ball': Kids With Type 2 Diabetes   Especially in underserved areas of Mississippi, children with type 2 diabetes face an uphill battle, and clinicians have to arm them appropriately for the fight.
  Medscape Diabetes & Endocrinology, August 2018
• 'Really Good' New Guidelines for T2 Diabetes   Dr Anne Peters applauds the latest changes to guidelines that put cardiovascular risk at the forefront of type 2 diabetes management.
  Medscape Diabetes & Endocrinology, July 2018
• New Diabetes Guidelines Already Outdated?   The ACP reviewed relevant studies but came to conclusions 'not germane to the way we treat patients with type 2 diabetes today,' says Dr Anne Peters.
  Medscape Diabetes & Endocrinology, April 2018
• Refer Medicare Patients for Free Diabetes Prevention Program   A new Medicare benefit can help patients prevent diabetes and improve other aspects of their health, says Dr Anne Peters.
  Medscape Diabetes & Endocrinology, March 2018
• New Diabetes Guidelines Fail to Guide   An effort to encourage individualized treatment choices may muddy the therapy waters, says Dr Peters.
  Medscape Diabetes & Endocrinology, January 2018
• 'Now Is the Time to Learn' About CGM   The FreeStyle Libre, a newly approved device for continuous glucose monitoring, is a big advance for people with diabetes who want to avoid finger sticks, says Dr Anne Peters.
  Medscape Diabetes & Endocrinology, November 2017
• Ultra-fast Insulins Curb Mealtime Spikes   Faster-acting insulins are especially beneficial for patients on continuous glucose monitors who are keeping track of glucose peaks and valleys.
  Medscape Diabetes & Endocrinology, October 2017
• Tips for Demystifying Injections in Diabetes   Dr Anne Peters demonstrates how she teaches injection techniques to patients with diabetes.
  Medscape Diabetes & Endocrinology, October 2017
• Helping Diabetes Patients Exercise Without Fear   Managing blood sugar during and after exercise can be challenging, but clinicians can help patients avoid highs and lows.
  Medscape Diabetes & Endocrinology, October 2017
• Two 'Incredibly Useful' Tools for Managing Diabetes   Dr Anne Peters demonstrates two continuous glucose monitors--one that provides blood glucose values in real time, and one that lets physicians see 2 weeks of values retrospectively.
  Medscape Diabetes & Endocrinology, September 2017
• Two New Combination Injectable Drugs for Type 2 Diabetes   These two new drug combinations will offer better glucose control and simplify the regimen for patients with inadequately controlled type 2 diabetes.
  Medscape Diabetes & Endocrinology, January 2017
• The First FDA-Approved Artificial Pancreas System   Dr Peters talks about the first hybrid closed-loop system to be approved by the FDA for the treatment of type 1 diabetes. What is it, how does it work, and what are its limitations?
  Medscape Diabetes & Endocrinology, January 2017
• 'Incredibly Exciting': Diabetes Drug With CV Benefits   The FDA's recent addition of a cardiovascular indication for diabetes drug empagliflozin is a significant milestone in diabetes care, says Dr Anne Peters.
  Medscape Diabetes & Endocrinology, December 2016
• Prediabetic Feet Deliver Profound Message   The healthy feet of patients with prediabetes represent a special opportunity for medical providers, says Dr Anne Peters.
  Medscape Diabetes & Endocrinology, November 2016
• 'We Need to Move Forward': CGM in Diabetes   Sensors matched with insulin pumps beat finger sticks and multiple daily injections, says Dr Anne Peters, so we need 'real science' to determine the value of continuous glucose monitoring in diabetes.
  Medscape Diabetes & Endocrinology, November 2016
• Diabetes Drugs: The Latest Good -- and Bad -- News   Dr Anne Peters discusses hot topics in type 2 diabetes treatment: liraglutide shows CV benefits, whereas some SGLT2 inhibitors show renal protection -- and potential harm.
  Medscape Diabetes & Endocrinology, August 2016
• New Metformin Rule 'Makes Me Incredibly Happy'   New prescribing guidelines for metformin will make clinicians' lives easier, and they are good for patients, too, says Dr Anne Peters.
  Medscape Diabetes & Endocrinology, June 2016
• Wait for It: Diabetes News Eagerly Anticipated   Dr Anne Peters reveals which stories she will be following during the upcoming meeting of the American Diabetes Association in New Orleans.
  Medscape Diabetes & Endocrinology, June 2016
• Lower CV Risk -- With a Diabetes Drug   Dr Peters shares a recent case where she prescribed diabetes drugs for the purpose of helping a patient reduce his cardiovascular disease risk.
  Medscape Diabetes & Endocrinology, April 2016
• What I Want for Christmas (Next Year)   Dr Anne Peters shares her holiday "wish list" for improvements in diabetes care in the coming year.
  Medscape Diabetes & Endocrinology, December 2015
• New Insulins: Benefits and Challenges   Dr Anne Peters explains why new insulin products have clinical benefits and how their higher costs can be managed, especially at the end of the year.
  Medscape Diabetes & Endocrinology, December 2015
• How EMPA-REG Has Changed My Practice   The EMPA-REG Outcomes trial found that the diabetes drug empagliflozin was not only safe but it actually provided cardiovascular benefits in high-risk patients.
  Medscape Diabetes & Endocrinology, November 2015
• Minimizing DKA Risk With SGLT2 Inhibitors in Type 1 Diabetes   Could dose titration and ketone monitoring make drugs designed for type 2 diabetes safe in type 1 diabetes?
  Medscape Diabetes & Endocrinology, October 2015
• Type 2 Diabetes Management: Choosing the Best Therapies   Two experts offer tips for sifting through the many drug options to help patients optimize management of their type 2 diabetes.
  Medscape Diabetes & Endocrinology, October 2015
• Demystifying the Glycemic Index: Implications for Practice   What characteristics give a food its glycemic index? What are the benefits of a low-glycemic diet? A nutritionist explains why a low-glycemic-index diet is a shortcut to health.
  Medscape Diabetes & Endocrinology, June 2015
• How to Counsel Type 1 Diabetes Patients Who Exercise?   Anne Peters and Bruce Bode discuss the optimal exercise prescription for athletes and patients with type 1 diabetes who want to exercise.
  Medscape Diabetes & Endocrinology, June 2015
• 'Understand This Warning': SGLT2s and Ketoacidosis   Dr Anne Peters describes case examples of euglycemic ketoacidosis linked to SGLT2 inhibitors used to treat type 2 diabetes.
  Medscape Diabetes & Endocrinology, June 2015
• CV Safety of Diabetes Drugs on ADA 2015 Program   Dr Anne Peters provides background on the cardiovascular risks of four oral diabetes drugs, which will be discussed at the upcoming annual meeting of the American Diabetes Association.
  Medscape Diabetes & Endocrinology, June 2015
• Inhaled Insulin: How to Teach Patients   Dr Anne Peters demonstrates the use of the new inhaled insulin device and reminds clinicians what to discuss with patients when initiating this new agent.
  Medscape Diabetes & Endocrinology, May 2015
• Tailoring Type 2 Diabetes Treatment: Updated Guidance   Updates to the ADA/EASD guidance on treating hyperglycemia in type 2 diabetes include a discussion of SGLT-2 inhibitors.
  Medscape Diabetes & Endocrinology, March 2015
• What's New in the ADA's Latest Diabetes Guidelines?   Dr Anne Peters discusses the changes to the standards of care updated annually by the American Diabetes Association.
  Medscape Diabetes & Endocrinology, February 2015
• Anne Peters: Advances in Diabetes, 2014 What were the most important developments in diabetes care this past year?
  Medscape Diabetes & Endocrinology, December 2014
• How Promising Is Brown Fat for Weight Loss?   Dr Anne Peters talks with Dr Mattias Blüher about the latest research on brown adipose tissue and the clinical applications under study.
  Medscape Diabetes & Endocrinology, October 2014
• 'Constant Feast' Drives Up Diabetes Rates in Saudi Arabia   Dr Anne Peters talks with Dr Aus Alzaid about the high rate of diabetes in Saudi Arabia, and the unique cultural considerations in managing and preventing diabetes in the Middle East.
  Medscape Diabetes & Endocrinology, September 2014
• EASD at 50: What's Driving the Future?   Sir George Alberti and Dr. Ele Ferrannini, former presidents of the European Association for the Study of Diabetes, talk with Dr. Anne Peters about how diabetes has evolved over the past 50 years.
  Medscape Diabetes & Endocrinology, September 2014
• Helping Diabetes Patients on 'Worst Day of My Life'   Dr. Anne Peters talks with Tami Ross, a leader in diabetes education, about how the healthcare team can help diabetes patients face their new diagnosis and go on to lead healthy, happy lives.
  Medscape Diabetes & Endocrinology, June 2014
• What Is an Artificial Pancreas, Really?   Whether you call it 'bionic' or 'artificial,' it's destined to revolutionize diabetes care but still fall short of some patients' expectations. Howard Zisser talks with Anne Peters at ADA 2014.
  Medscape Diabetes & Endocrinology, June 2014
• Fascinating Discoveries in Type 2 Diabetes   Dr. Anne Peters talks to Dr. Guy Rutter, who has made some amazing discoveries about beta-cell function in type 2 diabetes.
  Medscape Diabetes & Endocrinology, June 2014
• Once-Weekly Dulaglutide Effective for T2DM   Dr. Anne Peters and Dr. Kathleen Dungan discuss results of an open-label trial comparing weekly dulaglutide with daily liraglutide in type 2 diabetes.
  Medscape Diabetes & Endocrinology, June 2014
• Congratulations! We're Making Strides in Diabetes Care   Dr. Anne Peters reviews 3 studies that describe the state of diabetes care in the United States, with some encouraging results.
  Medscape Diabetes & Endocrinology, June 2014
• Getting to 'A-ha!' With Obese Patients   Dr. Anne Peters shares a patient's story of how she battled obesity and won.
  Medscape Diabetes & Endocrinology, April 2014
• Key Points in the ADA's New Diabetes Guidelines   Dr. Anne Peters discusses what's new and what remains important in the American Diabetes Association's 2014 revision of its Standards of Care for diabetes.
  Medscape Diabetes & Endocrinology, January 2014
• Anne Peters: The Year in Diabetes Although some of the year's advances represented only small steps for diabetes, they are steps toward improved care and quality of life for millions of patients.
  Medscape Diabetes & Endocrinology, December 2013
• How Do New Statin Guidelines Affect Diabetes Care? Although the new guidelines make LDL targets unnecessary, Dr. Anne Peters believes they still may have a place in treating patients with diabetes.
  Medscape Diabetes & Endocrinology, November 2013
• Gliptin Safety a 'Good Thing'   'It would have been nice' if the diabetes drugs had actually lowered cardiovascular risk, says Dr. Anne Peters.
  Medscape Diabetes & Endocrinology, September 2013
• Top Picks From ADA Dr. Anne Peters reports on the latest developments in the clinical management of diabetes, from the artificial pancreas to insulin, drugs, and combination agents.
  Medscape Diabetes & Endocrinology, July 2013
• Type 2 Diabetes in the Hospital: Glucose Management Dr. Kathleen Dungan talks with Dr. Anne Peters about key issues in managing type 2 diabetes patients who are hospitalized and then transitioned back to outpatient care.
  Medscape Diabetes & Endocrinology, June 2013
• Transplant Options for Patients With Type 1 Diabetes   Outcomes in whole-pancreas transplants continue to improve, as investigators study less invasive islet transplants. Dr. Michael Rickels discusses the latest developments with Dr. Anne Peters.
  Medscape Diabetes & Endocrinology, June 2013
• Beta Cells: 'Where It All Begins' How does dietary fat affect beta cell function in diabetes patients? Dr. Raghu Mirmira talks to Dr. Anne Peters about the research presented at the annual meeting of the American Diabetes Association.
  Medscape Diabetes & Endocrinology, June 2013
• AACE Algorithm Offers New Guidance on Managing T2DM   Dr. Anne Peters reviews the latest algorithm from the American Association of Clinical Endocrinologists for treating type 2 diabetes.
  Medscape Diabetes & Endocrinology, May 2013
• Canagliflozin: Who May Benefit From New Diabetes Drug?   Dr. Anne Peters discusses the clinical considerations in prescribing this first-in-class drug for type 2 diabetes.
  Medscape Diabetes & Endocrinology, April 2013
• An Unusual Case of Type 1 Diabetes -- or Is It Type 2?   Dr. Anne Peters describes her management of a lean Asian man who came to her with a diagnosis of type 1 diabetes.
  Medscape Diabetes & Endocrinology, March 2013
• Kazano! New Alogliptin Combos for Type 2 Diabetes   Dr. Anne Peters explains prescribing considerations for the newly approved alogliptin and its combination formulations.
  Medscape Diabetes & Endocrinology, February 2013
• What's New in ADA's Latest Diabetes Guidelines?   Dr. Anne Peters discusses the changes to the standards of care updated annually by the American Diabetes Association.
  Medscape Diabetes & Endocrinology, February 2013
• CGM: Practical Uses in Diabetes   Dr. Anne Peters discusses the real-life use of continuous glucose monitoring and recent advances in the technology.
  Medscape Diabetes & Endocrinology, January 2013
• Insulin for Prediabetes?   Dr. Anne Peters describes her personalized approach to treating a patient with prediabetes, using clinical trial data and the patient's input to come up with an unusual plan.
  Medscape Diabetes & Endocrinology, December 2012
• 'Why We Halted Look AHEAD'   Dr. Anne Peters, an investigator for Look AHEAD (Action for Health in Diabetes), explains the reasons for stopping this large national trial and provides perspective for clinicians to share with their patients.
  Medscape Diabetes & Endocrinology, October 2012
• How to Use New Type 2 Diabetes Guidelines   Dr. Anne Peters, an author of the ADA/EASD guidance issued earlier this year, offers a step-by-step guide to selecting the right medications for patients with type 2 diabetes.
  Medscape Diabetes & Endocrinology, September 2012
• Lean Adults With New Diabetes: Treatment Pearls   Dr. Anne Peters outlines key issues in the assessment and management of normal-weight patients who develop diabetes in adulthood.
  Medscape Diabetes & Endocrinology, September 2012
• ORIGIN Reassures Us of Insulin's Safety, Effectiveness   The results of the ORIGIN trial may not change clinical practice dramatically, says Dr. Anne Peters, but they reinforce the benefits of insulin without raising the risk for cardiovascular disease.
  Medscape Diabetes & Endocrinology, June 2012
• New Guidelines Clarify Treatment for Type 2 Diabetes   Clinicians can use the new guidelines to better navigate the many treatment options and deliver optimal, patient-centered care, says Dr. Anne Peters.
  Medscape Diabetes & Endocrinology, April 2012
• Bariatric Surgery a 'Magic Bullet' for Diabetes?   New research shows that bariatric surgery may produce better responses than standard medical therapy in obese patients with type 2 diabetes, but surgery is no panacea, warns Dr. Anne Peters.
  Medscape Diabetes & Endocrinology, April 2012
• Traveling With Diabetes: Help Your Patients Prepare   Patients who take insulin for diabetes may be nervous about traveling, but you can help them feel secure with these preparations explained by Dr. Anne Peters.
  Medscape Diabetes & Endocrinology, February 2012
• Bydureon: An Easy, Effective New Treatment for Type 2 Diabetes   How will the new once-weekly exenatide formulation fit into the overall diabetes armamentarium? Dr. Anne Peters offers a short overview.
  Medscape Diabetes & Endocrinology, January 2012
• I Was Shocked by What You Don’t Have   Dr. Anne Peters discusses diabetes care in Ethiopia with Dr. Ahmed Reja, President of the Ethiopian Diabetes Association, while attending the World Diabetes Congress in Dubai, UAE.
  Medscape Diabetes & Endocrinology, December 2011
• Diabetes Care in Poland: 'Just 1 Brick in Global System'   Dr. Leszek Czupryniak, President of Diabetes Poland, talks with Dr. Anne Peters about how diabetes care in Poland compares with that in other regions of the world.
  Medscape Diabetes & Endocrinology, December 2011
• What Does the Global Diabetes Epidemic Mean for US Clinicians?   The recent World Diabetes Congress offered important insights on diabetes from around the world, Dr. Anne Peters reports.
  Medscape Diabetes & Endocrinology, December 2011
• Managing Diabetes in Young Adults: New Guidelines   Pediatric patients with diabetes who are transitioning to adult care are particularly vulnerable, says Dr. Anne Peters, who co-chaired a committee that produced new clinical guidelines for these "emerging adults."
  Medscape Diabetes & Endocrinology, October 2011
• Alzheimer Risk in Diabetes: What to Tell Patients?   Patients with diabetes have been asking questions about 2 new studies related to risk for Alzheimer disease and possible treatment, reports Dr. Anne Peters.
  Medscape Diabetes & Endocrinology, October 2011
• Liraglutide's REMS: What's New?   A recent FDA drug advisory highlighted the potential risks of liraglutide (Victoza®) in the treatment of type 2 diabetes, but was there anything new in the data or guidance? Dr. Anne Peters discusses the issue.
  Medscape Diabetes & Endocrinology, September 2011
• How Does Linagliptin Compare With Other DPP-4 Inhibitors?   Linagliptin is the latest addition to the array of medications available to treat type 2 diabetes. Dr. Anne Peters describes its role in the overall armamentarium.
  Medscape Diabetes & Endocrinology, September 2011
• ADA Highlights: New Drugs for Diabetes   Dr. Anne Peters and Dr. Julio Rosenstock discuss the diabetes drugs that will be most important to practicing clinicians in the next few years.
  Medscape Diabetes & Endocrinology, August 2011
• Safety of Diabetes Drugs -- Should We Worry?   Dr. Anne Peters and Dr. John Buse discuss the risks and benefits of diabetes drugs that are getting headlines for safety reasons.
  Medscape Diabetes & Endocrinology, July 2011
• Building a Social Network for Type 1 Diabetes   Dr. Anne Peters speaks with Marie Schiller about innovative programs of the Helmsley Trust, which include an online network for patients with type 1 diabetes.
  Medscape Diabetes & Endocrinology, July 2011
• Real Life With Diabetes: What Clinicians Need to Hear   Website founder and type 1 diabetes patient Amy Tenderich describes the day-to-day battle of diabetes management from the patient's perspective.
  Medscape Diabetes & Endocrinology, July 2011
• Improving Continuous Glucose Monitoring Technology   Dr. Anne Peters speaks with Dr. Howard Wolpert about the benefits and limitations of continuous glucose monitoring and the "mechanical pancreas."
  Medscape Diabetes & Endocrinology, July 2011
• Can an IndyCar Driver With Type 1 Diabetes Still Race?   Dr. Anne Peters explains how she works with Charlie Kimball, the first licensed IndyCar driver with diabetes, whose car is outfitted with steering wheel monitors and a helmet juice pack.
  Medscape Diabetes & Endocrinology, April 2011
• ADA's Practice Guidelines for 2011   Dr. Anne Peters discusses the new ADA guidelines.
  Medscape Diabetes & Endocrinology, March 2011
• New Guideline Sets Higher Hospital Glycemia Targets   Dr. Anne Peters summarizes the latest guidance on glycemia control for hospitalized patients.
  Medscape Diabetes & Endocrinology, March 2011
• Diabetes in 2010: A1c, ACCORD, Avandia, Victoza, and More   Dr. Anne Peters looks back over the major milestones reached in 2010 for the diagnosis and management of diabetes.
  Medscape Diabetes & Endocrinology, December 2010
• TZDs for Diabetes: Tips for Safe Use   Dr. Anne Peters describes how she uses TZDs, especially pioglitazone, to maximize patients' management of diabetes while still heeding safety warnings.
  Medscape Diabetes & Endocrinology, November 2010
• 1 Patient, 3 Assessments: Which Is Best?   Diabetes management can take many different forms, as Dr. Anne Peters discusses in this video commentary
  Medscape Diabetes & Endocrinology, October 2010
• Common Supplements for Diabetes: Any Benefits?   Many patients with diabetes take supplements, such as cinnamon and fish oil. Dr. Anne Peters offers tips on how to advise patients about such therapies.
  Medscape Diabetes & Endocrinology, September 2010
• Emergency Kits for Patients With Diabetes: What's Needed?   Clinicians should advise patients with diabetes to prepare an emergency medical kit in case of disaster. Dr. Anne Peters shares her tips on what to pack.
  Medscape Diabetes & Endocrinology, September 2010
• Should We Continue Insulin Secretagogues When Starting Insulin for Type 2 Diabetes?   Dr. Anne Peters discusses new research that sheds light on this often perplexing question.
  Medscape Diabetes & Endocrinology, July 2010
• Transitioning Pediatric Patients With Diabetes to Adult Care   A gradual transition empowers patients to take charge of their diabetes management, explains Dr. Paola Sequeira in this discussion with Dr. Anne Peters.
  Medscape Diabetes & Endocrinology, July 2010
• What Key Lessons Emerged From ADA 2010?   Dr. David Kendall of the American Diabetes Association reviews highlights of the group's recent annual meeting with Dr. Anne Peters.
  Medscape Diabetes & Endocrinology, July 2010
• Avoiding Hypoglycemia: CGM Devices May Be the Answer   Dr. Howard Wolpert, an expert on continuous glucose monitors, discusses the importance of this technology with Dr. Anne Peters at the recent ADA annual meeting.
  Medscape Diabetes & Endocrinology, July 2010
• TZDs: Managing Fracture Risk -- In Men, Too   Dr. Anne Peters discusses ways to address the fracture risk associated with thiazolidinediones that are used to treat diabetes.
  Medscape Diabetes & Endocrinology, July 2010
• How Can We Help Our Overweight Patients?   Dr. Anne Peters discusses how to treat overweight and obese patients.
  Medscape Diabetes & Endocrinology, April 2010
• What Did ACCORD Teach Us About Hypertension Targets?   In this video editorial, Dr. Anne Peters reviews the "obvious" and more subtle lessons from ACCORD in regard to aggressive drug therapy to lower blood pressure and reduce cardiovascular risk in patients with type 2 diabetes mellitus
  Medscape Diabetes & Endocrinology, March 2010
• ACCORD Lipid Study Deserves Careful Review   Dr. Anne Peters looks beyond the hyped headlines to provide a reasoned analysis of ACCORD's findings on fenofibrate therapy in this video commentary.
  Medscape Diabetes & Endocrinology, March 2010
• Liraglutide: A New Treatment Option for Type 2 Diabetes Mellitus   Dr. Anne Peters reviews the benefits and risks of liraglutide in this short video commentary.
  Medscape Diabetes & Endocrinology, February 2010
• ADA Offers 3 New Diabetes Treatment Recommendations   Dr. Anne Peters discusses new guidelines for treating gestational diabetes, using aspirin to lower cardiovascular risk, and treating hospitalized patients with diabetes.
  Medscape Diabetes & Endocrinology, January 2010
• New ADA Diagnosis Guidelines: Putting Them Into Practice   Dr. Anne Peters discusses how the new focus on hemoglobin A1c values may affect your patients and your clinical practice.
  Medscape Diabetes & Endocrinology, January 2010